Related Experiment Video
Updated: Sep 2, 2025

07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
10.0K
Consent Builder: an innovative tool for creating research informed consent documents
Katherine A Sward1, Rene Enriquez2, Jeri Burr2
1Department of Nursing, University of Utah, Salt Lake City, Utah, USA.
JAMIA Open
|August 1, 2022
Summary
A new platform, Consent Builder, standardizes research consent documents across multicenter studies while allowing site-specific details. This innovation streamlines the informed consent process, though technical improvements are needed for broader adoption.
Area of Science:
- Clinical Research Operations
- Health Informatics
- Regulatory Science
Background:
- Multicenter studies require consistent yet adaptable informed consent documents.
- Existing processes for generating consent forms can be inefficient and prone to variation.
- Regulatory changes, such as the use of Single Institutional Review Board (sIRB), increase the need for standardized documentation.
Purpose of the Study:
- To describe process innovations for research informed consent documents.
- To detail the development and formative evaluation of Consent Builder, a platform for generating consent documents for multicenter studies.
Main Methods:
- Analysis of Institutional Review Board (IRB) workflows and documents.
- Process and document redesign, followed by software development leveraging REDCap and LaTeX.
- Conducting a small-scale usability study of the Consent Builder platform.
Main Results:
- Developed a 2-part informed consent document structure: standardized study description and local site verbiage.
- Implemented Consent Builder in the Trial Innovation Network, receiving acceptable user survey scores with noted areas for improvement.
- Identified LaTeX coding as a significant challenge for users.
Conclusions:
- Demonstrated a proof-of-concept for generating consistent, customizable research consent documents across study sites.
- Consent Builder represents an operational innovation addressing needs arising from sIRB regulations for multicenter trials.
- Process changes were generally accepted, but technical modifications are recommended for widespread implementation due to observed variability in IRB workflows.
Related Concept Videos
Ethics in Research
23.8K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.8K
Nurses' Legal Responsibilities I
838
In healthcare, informed consent is a crucial process that involves thoroughly communicating medical treatment options to patients, including benefits, risks, potential side effects, and alternatives. This process enables patients to make well-informed decisions about their care, ensuring they understand the implications of their choices before consenting to or refusing treatment.
The legal responsibilities of a nurse regarding informed consent include the following:
The legal responsibilities of a nurse regarding informed consent include the following:
838
Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
7.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.0K
Experimental Designs
11.8K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.8K

